Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

ESMO 2016 /
Coming of age for CDK 4/6 inhibitors: Interactive session and close

7th - 11th Oct 2016

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 26.10.16
Views: 1536

Dr Giuesppe Curigliano - European Institute of Oncology, Milan, Italy

Dr Curigliano chairs this closing session at the 'Coming of age for CDK 4/6 inhibitors' symposium at ESMO 2016.

He reaffirms the key take-home messages for breast oncologists and support professionals in this interactive question and answer session.

Supported by a grant from Pfizer Inc.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation